Member Info for Bella6532

Energyshares...

How long does it take to put together a deal.

How many are we negotiating with.

Both above are unknowns but my guess is we have at least one on the hook.

Not presenting at JPM conference may or may not be an indicator we don't need to.

Also Al's reference to funding not going to be a problem and fact we are now in commercialisation stage also might be an indicator of an upcoming commercialisation partnership which I do feel is highly likely.

Also the move to a two weekly trial could have been called for by a third party too.

Timster...and affimers

'Affimer reagents not only block the spike-ACE2 binding but efficiently prevent a SARS-COV-2 model virus from entering human cells'

Affimers could be used to block the spike-ACE2 binding which is like having a vaccination or preventative measure. However what about those with Long Covid. AVA6000 targets FAP. Could they develop a PreCision that target Covid which is still attached to ACE in hidden pockets within the body.

Friends of ours have had Covid 5 times. They've also had 5 vaccinations. Each time they've gone down with Covid they are finding the symptoms, like brain fog and fatigue, are lasting longer and longer. Question is, how much Covid is still hidden in various hard to reach pockets in their body. They had their last vaccinations early December. caught Covid two weeks later from someone they knew. After 10 days they tested negative. Over Christmas he got very cold at an outside event and the next day went down with full blown Covid symptoms which it appears was the Covid still in his system flaring up again.

Long Covid is a big problem and will only get worse as people continue to catch Covid - so what if anything can Avacta or a partner come up with to get ride of any Covid lingering in the deep dark corners....

One for PreCision perhaps...

https://www.healthcentral.com/condition/coronavirus/covid-after-a-negative-test

SuePud1...Oh! Please..go back and check what AS said...don't worry about the money...

There won't be a fundraiser...

BTW they keep sneaking in...

27-Dec-23 13:50:15 111.25 100,000 Sell* 111.00 113.00 111.25k

OK so 100K isn't soooo big but it's good to see...

If this is a Sell, then who bought...who is the HNWI...

I really dpon't think we are going to be bought out...but I do feel there could be a good AA or JV deal to be had and surely that deal is just pending official FDA now...

Profcheese...afraid the biggest problem with prostate cancer diagnosis is you guys and your crossed leg syndrome. The sooner men go and get tested regularly the better for we women who spend our days nagging you lot to go and get tested. Nuff said... Haha...

Finally, I wish everyone a very safe, healthy and happy Christmas and New Year. Cheers...

AVA6000

02 Apr 2020

'Positive data could lead to a significant licensing opportunity for AVA6000 with companies currently marketing existing Doxorubicin products or with companies that are currently carrying out clinical studies combining Doxorubicin with their checkpoint inhibitors.'

https://avacta.com/subscription-to-raise-2-million/

So we have the positive data and a new chappie to go after the target market (which I'm sure is the same as it was back in April 2020).

Everything else right now is just noise, speculation, guesswork etc etc.

DTW...yes I know...I used £1m just to refer to it being a large trade...slap my wrists eh for lack of detail...

Anyway it's a shed load...typo is one thing but if it really was a legit trade then I doubt it was just the buyer saying sorry I had a change of mind just as it was put through.

Sorry for backtracking, but it's been puzzling me as to why the £1m trade was backed out.

Was it a typo type mistake or the final trade in a worked through order ?

If the latter, did the buyer cancel his order or has he actually increased it?

I would be very surprised if was due to the order being cancelled and more likely the buyer increased the order.

If so, then why not keep the £1m in place and start a new order process....perhaps it's to make it look like a cancelled order to release some more sticky shares or to avoid a TR1 just yet. Who knows but I guess we will eventually get to know one way or the other as time passes.

Experience

Simon Bennett Associates Ltd Graphic

Managing Director

Simon Bennett Associates Ltd

Jul 2010 - Present 13 years 6 months

Oxford, United Kingdom

Business Development, Licensing and Market Research support to the Biotech, Pharmaceutical and Life Sciences Industries. Clients include:

CS Pharmaceuticals, Xobaderm, Torrey Pines Investment & Beijing Tide Pharma

Previous clients include:

YourEncore: Consultant including scouting for opportunities in Europe for Bristol-Myers Squibb

Menarini Biotech: CMO Business Development

Black Diamond Therapeutics: Business Development Scouting Consultant

Oxford PharmaScience: Head of Business Development Biotech: Business Development

Midatech Pharma: Business Development Consultant

IGA-Technology Services: Business Strategy Consultant & Business Development

Remedy Pharmaceuticals: Business Development Consultant

Imperial Innovations: Business Development Consultant

Glide Technologies: Business Development Consultant

InhibOx: Business Development - Europe

Arecor: Business Development and Strategy Consultant

EmulTech: Business Development and Strategy Consultant

Tarix Pharmaceuticals: Business Development

Crucial Genetics: Interim Chief Operating Officer

VacZine Analytics: Senior Consultant

Oxford Innovation (Business Link West Midlands): SME growth adviser

Here is a 2020 RNS..see AVA6000 comments...

https://avacta.com/subscription-to-raise-2-million/

This fundraise brought in the Boohoo guys and there aren't too many Dox companies they saw back then as their target market...who has been waiting for this data?

'These emerging data give us, for the first time, the opportunity to accelerate ongoing discussions as well as to generate new opportunities...'

Note...' accelerate ongoing'

And his involvement in RTO of Nasdaq listed company...that's my bet on the way they'll go...

Energyshares...Shaun Chilton is currently Non-Exect Chair for MAP Patient Access Limited

Pharmaceutical Manufacturing

Cambridge, Cambridgeshire .

Pulling order...Rudolph, then Dasher, Dancer, Prancer, Vixen, Comet, Cupid, Donner and Blitzen.

Comit 6 and Cupid 7...

Anything to do with security in finance too per chance?

Oh...buying eh!...which one...BooHoo or Zeus or both. If Boohoo is Zeus brokering the deal perhaps?

If it was simply one entity selling to another I reckon we will see the other half of the trade filed late. Or those odd £200 trades we saw a few days back were part of this and done as a work through over several days/weeks. If they're done I think the number of unknown trades per day and filed late will disappear...if not then the buying/selling spree will continue.

If Boohoo boy(s) selling ?

So who then is buying?

Ophidian...you reckon one or both of our HNWI's are selling?

Timster...another unknown...and a big'un...

Now which II is that do you think...?

111.50 1,334,412 Unknown* 1m